Drugs Health Pharma

China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies

China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development.

Read More
Drugs Health Pharma

Global health agency recommends Takeda’s dengue vaccine Qdenga 

HQ Team October 3, 2023: The WHO has recommended Japanese drugmaker Takeda Pharmaceutical Co’s Qdenga vaccine for dengue where there is a high.

Read More